Sex: Male
Histology: Small cell lung cancer
Key Mutations: TP53 G154Afs*16, RB1 X203_splice, PTEN L181Wfs*13,
MYCN Amplified
Molecular Characteristics: MSK-IMPACT, whole exome sequencing
Matched Normal: Yes
Treatment: cisplatin + etoposide
Site: Lung
Paired: Yes
Comments: Chemosensitive relapse
Licensing Information: Corporations and other for-profit entities may nonexclusively license Memorial Sloan Kettering’s tangible materials for research or commercial purposes. For more information, please contact [email protected].
Stage of Development
Ready to use